期刊文献+

胺碘酮用于房颤复律及维持窦律的随访观察 被引量:3

Effect of amiodarone on cardioverison and maintaining sinus rhythm in atrial fibrillation patients
下载PDF
导出
摘要 目的 :观察胺碘酮用于房颤复律及转复后维持窦律的长期疗效和安全性。方法 :对病程 18m o内的 32例房颤患者用胺碘酮片 6 0 0 m g/ d,用药的前 3d加用 40 0~ 6 0 0 mg/ d胺碘酮注射液 iv gtt,复律后维持低剂量 (2 0 0 m g/ d)的胺碘酮治疗且随访 3a。结果 :有 30例患者复律成功。维持窦律的有效率 :6 mo为 6 9.7% ,12 m o为 93.3% ,2 4m o为 86 .7% ,36 m o为 73.3%。结论 :胺碘酮是房颤转复及维持窦律的有效药物。 AIM: To study the effect of amiodarone on cardioverison and maintaining sinus rhythm in atrial fibrillation. METHODS: Thirty two patients with atrial fibrillation using amiodarone 400-600 mg/d by intravenous infusion for 3 d and 600 mg/d by oral administration for 1 wk, then oral for maintaining dose (200 mg/d) following up for 36 mo. RESULTS: 6 mo, 12 mo, 24 mo and 36 mo after amiodarone treatment. The clinical effective rate was 96 7%, 93 3%, 86 7% and 73 3% respectively. CONCLUSION: Amiodarone may provide an effective therapeutic approach to cardioverison and maintaining sinus rhythm in patients with atrial fibrillayion.
出处 《中国临床药学杂志》 CAS 2000年第6期338-339,共2页 Chinese Journal of Clinical Pharmacy
关键词 心房颤动 胺碘酮 复律 维持窦律 药物治疗 atrial fibrillation amiodarone cardioverison
  • 相关文献

参考文献2

二级参考文献19

  • 11,Coplen SE,Antman EM,Berlin JA,etal.Efficacy and safety of quinidine therapy for maintenance of sinus rhythm aftercardioversion.A meta-analysis of radomized controlled trials.Circulation,1990,82∶1106-1116.
  • 22,Reinmold SC,Cantillon CO,Friedman PL,et al.Propafenone versus sotalol for suppressionof recurrent symptomatic atrial fibrillation.Am J Cardiol,1993,71∶558-563.
  • 33,Falk RH.Flecainide-induced ventricular tachycardia and fibrillation in patientstreated for atrial fibrillation.Ann Intern Med,1989,111∶107-111.
  • 44,De Simorie A,Stabile G,Vital DF,et al.Pretreatment with verapamil in patients withpersistent or chronic atrial fibrillation who underwent electrical conversion.J Am CollCardiol,1999,34∶810-815.
  • 55,Blevins RD,Kerin NZ,Benaderet D,et al.Amiodarone in the management of refractoryatrial fibrillation.Arch Intern Med,1987,147∶1401-1404.
  • 66,Brodsky MA,Allen BJ,Walker CJ,et al.Amiodarone for maintenance of sinus rhythm afterconversion of atrial fibrillation in the setting of a dilated left atrium.Am JCardiol,1987,60∶572-575.
  • 77,Gosselink ATM,Crijns HJGM,van Gelder IC,et al.Low-dose amiodarone for maintenance ofsinus rhythm after cardioversion of atrial fibrillation or flutter.JAMA,1992,267∶3289-3293.
  • 88,Chun SH,Sager PT,Stevenson WG,et al.Long-term efficacy of amiodarone for themaintenance of normal sinus rhythm in patients with refractory atrial fibrillation orflutter.Am J Cardiol,1995,76∶47-50.
  • 99,Gold RL,Haffajee CI,Charos G,et al.Amiodarone for refractory atrial fibrillation.Am JCardiol,1986,57∶124-127.
  • 1010,Hohnloser SH,Klingenheben T,Singh BN.Amiodarone-associated proarrhythmic effects.Areview with special reference to torsade de pointes tachycardia.Ann Intern Med,1994,121∶529-535.

共引文献29

同被引文献8

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部